Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theranostics

Showing results (881-890 of 5,522) with videos related to

Pageof 553
Sort By:
Theranostics|July 21, 2020
Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer TreatmentTingsheng Lin, Qing Zhang, Ahu Yuan, et al.
Theranostics|July 21, 2020
Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to FerroptosisJaewang Lee, Ji Hyeon You, Daiha Shin, et al.
Theranostics|July 21, 2020
COVID-19: Progress in diagnostics, therapy and vaccinationXue Liu, Chao Liu, Gang Liu, et al.
Theranostics|July 21, 2020
Interleukin-22 acts as a mitochondrial protectorSeonghwan Hwang, Dechun Feng, Bin Gao
Theranostics|July 21, 2020
Urine biopsy technologies: Cancer and beyondChun Kwan Chen, Junchen Liao, Man Sze Li, et al.
Theranostics|August 18, 2020
METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modificationsDongdong Jian, Ying Wang, Liguo Jian, et al.
Theranostics|August 18, 2020
Tumor Microenvironment-triggered Nanosystems as dual-relief Tumor Hypoxia Immunomodulators for enhanced PhototherapyZijun Shen, Junfei Xia, Qingming Ma, et al.
Theranostics|August 18, 2020
A novel nucleolin-binding peptide for Cancer TheranosticsJae-Hyun Kim, Chanhyung Bae, Min-Jung Kim, et al.
Theranostics|August 18, 2020
GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal CarcinomaShi-Lu Chen, Qun-Sheng Huang, Yu-Hua Huang, et al.
Theranostics|August 18, 2020
Targeting phosphatidylserine for Cancer therapy: prospects and challengesWenguang Chang, Hongge Fa, Dandan Xiao, et al.
Pageof 553

Showing results (881-890 of 5,522) with videos related to

Sort By:
Pageof 553
Theranostics|July 21, 2020
Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer TreatmentTingsheng Lin, Qing Zhang, Ahu Yuan, et al.
Theranostics|July 21, 2020
Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to FerroptosisJaewang Lee, Ji Hyeon You, Daiha Shin, et al.
Theranostics|July 21, 2020
COVID-19: Progress in diagnostics, therapy and vaccinationXue Liu, Chao Liu, Gang Liu, et al.
Theranostics|July 21, 2020
Interleukin-22 acts as a mitochondrial protectorSeonghwan Hwang, Dechun Feng, Bin Gao
Theranostics|July 21, 2020
Urine biopsy technologies: Cancer and beyondChun Kwan Chen, Junchen Liao, Man Sze Li, et al.
Theranostics|August 18, 2020
METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modificationsDongdong Jian, Ying Wang, Liguo Jian, et al.
Theranostics|August 18, 2020
Tumor Microenvironment-triggered Nanosystems as dual-relief Tumor Hypoxia Immunomodulators for enhanced PhototherapyZijun Shen, Junfei Xia, Qingming Ma, et al.
Theranostics|August 18, 2020
A novel nucleolin-binding peptide for Cancer TheranosticsJae-Hyun Kim, Chanhyung Bae, Min-Jung Kim, et al.
Theranostics|August 18, 2020
GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal CarcinomaShi-Lu Chen, Qun-Sheng Huang, Yu-Hua Huang, et al.
Theranostics|August 18, 2020
Targeting phosphatidylserine for Cancer therapy: prospects and challengesWenguang Chang, Hongge Fa, Dandan Xiao, et al.
Pageof 553